Stocks
Neurotrope (NTRP) ROE US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -100.7% | -57.4% | -171.3% | 0.00% | -137.4% | -242.7% | ||
| Changes by years, y/y, % | -14pp | +43pp | -114pp | +171pp | +8.1% | ||||
Neurotrope. ROE, %
Neurotrope. ROE, changes, pp
Neurotrope (NTRP) ROE US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| ROE, % | ? | 715.0% | -137.4% | -188.9% | -233.5% | -242.7% | -242.7% | |
| Changes by years, y/y, % | +534pp | +164pp | -958pp | |||||
| Changes by quarters, q/q, % | +1 016pp | -852pp | -51pp | -45pp | -9pp | |||
